Approval · Notice of Compliance 35595 · 2025
GLN-EZETIMIBE: Notice of Compliance 35595
Issued June 27, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35595
- Date
- June 27, 2025
- Company
- Glenmark Pharmaceuticals Canada Inc.Concord, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Change in the manufacturing process for the drug substance
- Canadian reference product
- EZETROL (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLN-EZETIMIBE | Not yet assigned | — |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB